Publications by authors named "Josef Dirschinger"

Claim this Profile
[
[Intracoronary Stenting and Angiographic Results Strut Thickness Effect on Restenosis Outcome (ISAR-STEREO) Trial].
Adnan Kastrati, Julinda Mehilli, Josef Dirschinger, Franz Dotzer, Helmut Schuhlen

Vestn Rentgenol Radiol· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Statin effect on thrombin inhibitor effectiveness during percutaneous coronary intervention: a post-hoc analysis from the ISAR-REACT 3 trial.
Ahmed A Khattab, Gjin Ndrepepa, Stefanie Schulz, Franz-Josef Neumann, Julinda Mehilli, Josef Dirschinger

Clin Res Cardiol· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
One-year clinical outcomes with abciximab in acute myocardial infarction: results of the BRAVE-3 randomized trial.
Stefanie Schulz, K Anette Birkmeier, Gjin Ndrepepa, Werner Moshage, Franz Dotzer, Josef Dirschinger

Clin Res Cardiol· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erythropoietin in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomized, double-blind trial.
Ilka Ott, Stefanie Schulz, Julinda Mehilli, Stefanie Fichtner, Martin Hadamitzky, Josef Dirschinger

Circ Cardiovasc Interv· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Paclitaxel- versus sirolimus-eluting stents for unprotected left main coronary artery disease.
Julinda Mehilli, Adnan Kastrati, Robert A Byrne, Olga Bruskina, Raisuke Iijima, Josef Dirschinger

J Am Coll Cardiol· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Abciximab in patients with acute ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention after clopidogrel loading: a randomized double-blind trial.
Julinda Mehilli, Adnan Kastrati, Stefanie Schulz, Stefan Früngel, Stephan G Nekolla, Josef Dirschinger

Circulation· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction.
Melchior Seyfarth, Dirk Sibbing, Iris Bauer, Georg Fröhlich, Lorenz Bott-Flügel, Josef Dirschinger

J Am Coll Cardiol· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bivalirudin versus unfractionated heparin during percutaneous coronary intervention.
Adnan Kastrati, Franz-Josef Neumann, Julinda Mehilli, Robert A Byrne, Raisuke Iijima, Josef Dirschinger

N Engl J Med· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of abciximab on clinical and angiographic restenosis in patients with non-ST-segment elevation acute coronary syndromes.
Raisuke Iijima, Gjin Ndrepepa, Julinda Mehilli, Josef Dirschinger, Jürgen Pache

Am J Cardiol· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Troponin level and efficacy of abciximab in patients with acute coronary syndromes undergoing early intervention after clopidogrel pretreatment.
Raisuke Iijima, Gjin Ndrepepa, Julinda Mehilli, Franz-Josef Neumann, Stefanie Schulz, Josef Dirschinger

Clin Res Cardiol· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
One-year clinical outcomes with abciximab vs. placebo in patients with non-ST-segment elevation acute coronary syndromes undergoing percutaneous coronary intervention after pre-treatment with clopidogrel: results of the ISAR-REACT 2 randomized trial.
Gjin Ndrepepa, Adnan Kastrati, Julinda Mehilli, Franz-Josef Neumann, Jurriën ten Berg, Josef Dirschinger

Eur Heart J· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sex and effect of abciximab in patients with acute coronary syndromes treated with percutaneous coronary interventions: results from Intracoronary Stenting and Antithrombotic Regimen: Rapid Early Action for Coronary Treatment 2 trial.
Julinda Mehilli, Gjin Ndrepepa, Adnan Kastrati, Franz-Josef Neumann, Jurriën ten Berg, Josef Dirschinger

Am Heart J· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sustained increased risk of adverse cardiac events over 5 years after implantation of gold-coated coronary stents.
Jürgen Pache, Alban Dibra, Christian Schaut, Helmut Schühlen, Josef Dirschinger

Catheter Cardiovasc Interv· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Age-dependent effect of abciximab in patients with acute coronary syndromes treated with percutaneous coronary interventions.
Gjin Ndrepepa, Adnan Kastrati, Julinda Mehilli, Franz-Josef Neumann, Jurriën ten Berg, Josef Dirschinger

Circulation· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Abciximab and angiographic restenosis after coronary stent placement. Analysis of the angiographic substudy of ISAR-REACT--a double-blind, placebo-controlled, randomized trial evaluating abciximab in patients undergoing elective percutaneous coronary interventions after pretreatment with a high loading dose of clopidogrel.
Helmut Schühlen, Adnan Kastrati, Julinda Mehilli, Jörg Hausleiter, Josef Dirschinger

Am Heart J· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive factors of restenosis after coronary implantation of sirolimus- or paclitaxel-eluting stents.
Adnan Kastrati, Alban Dibra, Julinda Mehilli, Sandra Mayer, Susanne Pinieck, Josef Dirschinger

Circulation· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Abciximab in patients with acute coronary syndromes undergoing percutaneous coronary intervention after clopidogrel pretreatment: the ISAR-REACT 2 randomized trial.
Adnan Kastrati, Julinda Mehilli, Franz-Josef Neumann, Franz Dotzer, Jurriën ten Berg, Josef Dirschinger

JAMA· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stem cell mobilization by granulocyte colony-stimulating factor in patients with acute myocardial infarction: a randomized controlled trial.
Dietlind Zohlnhöfer, Ilka Ott, Julinda Mehilli, Kathrin Schömig, Fabian Michalk, Josef Dirschinger

JAMA· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized trial of paclitaxel- and sirolimus-eluting stents in small coronary vessels.
Julinda Mehilli, Alban Dibra, Adnan Kastrati, Jürgen Pache, Josef Dirschinger

Eur Heart J· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized trial of a nonpolymer-based rapamycin-eluting stent versus a polymer-based paclitaxel-eluting stent for the reduction of late lumen loss.
Julinda Mehilli, Adnan Kastrati, Rainer Wessely, Alban Dibra, Jörg Hausleiter, Josef Dirschinger

Circulation· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized, double-blind, placebo-controlled trial on restenosis prevention by the receptor tyrosine kinase inhibitor imatinib.
Dietlind Zohlnhöfer, Jörg Hausleiter, Adnan Kastrati, Julinda Mehilli, Christoph Goos, Josef Dirschinger

J Am Coll Cardiol· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relationship between residual blood flow in the infarct-related artery and scintigraphic infarct size, myocardial salvage, and functional recovery in patients with acute myocardial infarction.
Gjin Ndrepepa, Adnan Kastrati, Markus Schwaiger, Julinda Mehilli, Christina Markwardt, Josef Dirschinger

J Nucl Med· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevention of restenosis by a novel drug-eluting stent system with a dose-adjustable, polymer-free, on-site stent coating.
Jörg Hausleiter, Adnan Kastrati, Rainer Wessely, Alban Dibra, Julinda Mehilli, Josef Dirschinger

Eur Heart J· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inflammatory response after intervention assessed by serial C-reactive protein measurements correlates with restenosis in patients treated with coronary stenting.
Alban Dibra, Julinda Mehilli, Siegmund Braun, Martin Hadamitzky, Hannsjörg Baum, Josef Dirschinger

Am Heart J· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Paclitaxel-eluting or sirolimus-eluting stents to prevent restenosis in diabetic patients.
Alban Dibra, Adnan Kastrati, Julinda Mehilli, Jürgen Pache, Helmut Schühlen, Josef Dirschinger

N Engl J Med· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis